Combined effect of alpha-fetoprotein antisense oligodeoxy-nucleotides and 5-fluorouracil on human hepatoma cell growth

Chinese Medical Journal

Volumn 112, Issue 8, 1999, Pages 743-746

  Wang, Xingwang ^a   Zhang, Rugang ^a   Xie, Hong ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

5 fluorouracil; Alpha fetoprotein antisense oligodeoxynucleotides; Combined effect; In vitro; Liver cancer cell growth

Indexed keywords

ALPHA FETOPROTEIN; ANTISENSE OLIGODEOXYNUCLEOTIDE; FLUOROURACIL; ONCOPROTEIN;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL GROWTH; CONTROLLED STUDY; GENE THERAPY; GROWTH INHIBITION; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MULTIMODALITY CANCER THERAPY;

ALPHA-FETOPROTEINS; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; FLUOROURACIL; HUMANS; LIVER NEOPLASMS; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; TUMOR CELLS, CULTURED;

EID: 0032855657     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Wang XW, Xu B. Stimulation of tumor - cell growth by alpha-fetoprotein. Int J Cancer 1998;75:596-599.
2. Wang XW, Xie H. Alpha-fetoprotein enhances the proliferation of human hepatoma cells in vitro. Life Sci 1999;64:17-23.
3. Semenkova LN, Dudich EI, Dudich IV. Induction of apoptosis in human hepatoma cells by alpha-fetoprotein. Tumor Biol 1997;18: 261-273.
4. Dudich EI, Semenkova LN, Gorbatova E, et al. Growth-regulative activity of human alpha-fetoprotein for different types of tumor and normal cells. Tumor Biol 1998;19:30-40.
5. Yao Z. Progress of basic studies on liver cancer in China. Chin J Oncol 1979;1:230-232.
6. Morinaga T, Sakai M, Wegmann TG, et al. Primary structures of human alpha-fetoprotein and its mRNA. Proc Nad Acad Sci U S A 1983;80:4604-4608.
7. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-580.
8. Denizot F, Lang R. Rapid colorimetric assay for cell growth and surviva. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986;89:271-277.
9. Alley MC, Scudiero DA, Monks A, et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 1988;48:589-601.
10. Wang XW, Xu B. In situ hybridization and immunocytochemistry for the investigation of alpha-fetoprotein gene expression in human BEL-7404 hepatoma cells. Chin J Histochem Cytochem 1997;6:259-263.
11. Wang XW, Xu B. Immunostimulatory action of L-4-oxalysine counteracts immunosuppression induced by alpha-fetoprotein. Eur J Pharmacol 1998;351:105-111.
12. Spears CP, Gustavsson BG, Mitchell MS, et al. Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracil. Cancer Res 1984;44:4144-4150.
13. Cory JG, Breland JC, Carter GL. Effect of 5-fluorouracil on RNA metabolism in Novikoff hepatoma cells. Cancer Res 1979;39: 4905-4913.
14. Patt YZ, Yoffe B, Charnsangavej C, et al. Low serum alpha-fetoprotein level in patients with hepatocellular carcinoma as a predictor of response to 5-FU and interferon-alpha-2b. Cancer 1993;72:2574-2582.
15. Horikoshi T, Danenberg KD, Stadlbauer TH, et al. Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reaction. Cancer Res 1992;52:108-116.
16. Ueda M, Kumagai K, Ueki K, et al. Growth inhibition and apoptotic cell death in uterine cervical carcinoma cells induced by 5-fluorouracil. Int J Cancer 1997;71:668-674.
17. Wang XW, Xie H. Growth inhibition of human liver cancer cells by alpha-fetoprotein antisense strategy. In Vitro Cell Dev Biol-Animal 1999;35 (in press).
18. Wang XW, Xie H. Studies on alpha-fetoprotein should be further strengthened. Nat Med J Chin 1998;78:723-724.